Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
The Section of Bioinformatics, DTU Health Tech is world leading within Immunoinformatics and Machine-Learning. Currently, we are seeking a highly talented and motivated PhD student within the field
-
Job Description The Section of Bioinformatics, DTU Health Tech is world leading within Immunoinformatics and Machine-Learning. Currently, we are seeking a highly talented and motivated PhD student
-
Experience with yeast physiology and advanced molecular biology. Experience with HT-screening devices and bioreactors. Bioinformatics knowledge (e.g. proteomics, RNAseq, genomics) DC9: Enhanced sustainable
-
bioinformatics and experience or interest in data analysis or the physiology of the human body, including heart, kidney and gut microbiome. The job can potentially be continued in a PhD position. As a person, you
-
- cancerous- and neurodegenerative diseases. In the project, patient cells, model- and reporter-minigenes, gene editing and animal models, as well as in vitro RNA binding techniques and bioinformatics will be
-
biology, pharmacology and/or immunology. Experience in statistical bioinformatics, including developing analysis pipelines and applying programming (R/Python) to genomic/transcriptomic data. Strong written
-
. Strong interest in and understanding of bioinformatics. Good communication skills in English, both written and oral. Experience with international collaboration and the ability to work effectively in
-
analytical equipment and microfluidics platforms. Strong interest in and understanding of bioinformatics. Good communication skills in English, both written and oral. Experience with international
-
: Data Mining Machine Learning Bioinformatics The successful candidate will contribute to advancing state-of-the-art in data mining and machine learning research with applications in computational biology
-
interface of microbiology, chemical ecology, bioinformatics and drug discovery, contributing understanding that can support development of new antibiotics against Gram-negative bacteria. The project is funded